Sectors we serve
Specialist search for the companies building what comes next.
EuropeFrom therapeutic innovators to the partners and platforms that make development possible.
We work where scientific complexity, regulated delivery, and a scarce talent market make general recruitment ineffective.
Our sector coverage follows the full life sciences ecosystem. Each search starts with the program, operating environment, and evidence the person must bring, not a list of titles copied from the market.
Advanced modalitiesCell and gene therapy
Leadership search across cell therapy, gene therapy, viral vectors, gene editing, and ATMP development from discovery through commercial manufacturing.
Explore relevant expertise ↗ The strongest candidates understand where the platform, process, clinical plan, regulatory path, and patient journey meet. We evaluate the work behind the title, including modality, development stage, scale, and decisions owned.
Scientific leadershipCMC and process developmentMSAT and technology transferQuality and regulatoryClinical and medicalCommercial and executive
Contract manufacturingCDMO
Executive and specialist search for development and manufacturing partners working across complex biologics, advanced therapies, sterile products, and specialist modalities.
Explore relevant expertise ↗ A CDMO leader must balance scientific credibility, client delivery, capacity, quality, and margin. We look for people who can translate technical capability into dependable execution and long-term client trust.
Site and general managementTechnical operationsMSAT and manufacturingQuality and complianceSupply chainBusiness development and key accounts
Drug development servicesCRO
Search for scientific, operational, and commercial leaders across clinical, preclinical, analytical, regulatory, and specialist research services.
Explore relevant expertise ↗ CRO growth depends on leaders who can protect delivery while expanding trusted client relationships. We assess technical authority, operational ownership, service-line economics, and evidence of complex stakeholder management.
Business unit leadershipClinical operationsScientific servicesQuality and regulatoryBusiness developmentExecutive and board
Targeted oncologyAntibody-drug conjugates
Specialist search across antibody engineering, linker and payload science, bioconjugation, analytical control, clinical development, and oncology commercialization.
Explore relevant expertise ↗ ADC programs create interdependent technical risks. The right leader must connect biology, chemistry, manufacturing, safety, and indication strategy without losing sight of developability or the patient population.
Discovery and translationalCMC and analyticalBioconjugationHighly potent manufacturingClinical developmentRegulatory and medical
Therapeutic companiesBiotech and pharma
Leadership hiring for emerging biotech, specialty pharma, and established pharmaceutical organizations building, developing, and launching differentiated medicines.
Explore relevant expertise ↗ Stage matters. A discovery company, a clinical-stage biotech, and a commercial portfolio need different versions of the same title. We define the evidence required now, then find leaders who have operated at that exact point of change.
Research and developmentCMC and technical operationsRegulatory and qualityClinical and medicalMarket access and commercialC-suite and board
Digital infrastructureLife sciences software
Search for leaders building data, workflow, analytics, and software products for drug discovery, clinical development, regulatory work, quality, and manufacturing.
Explore relevant expertise ↗ The best people in this market can move between scientific users and enterprise buyers. We look for leaders who understand validated environments, complex sales, implementation, data governance, and measurable customer value.
Product and strategyScientific solutionsEnterprise salesStrategic partnershipsCustomer successGeneral management
Start a conversation
Need depth in one of these markets?
Share the company stage, the program, and the leadership problem. The first conversation is confidential.
Discuss your search ↗